Effect of Visceral Adipose Tissue on Polycystic Ovary Syndrome: Review Article

Abstract

Background: Polycystic ovary syndrome (PCOS) is one of the most common endocrine disorders among women of reproductive age, affecting approximately 6–20% of this population worldwide depending on diagnostic criteria. It is characterized by chronic anovulation, hyperandrogenism, and polycystic ovarian morphology. However, beyond the reproductive manifestations, PCOS represents a complex metabolic disorder associated with insulin resistance, obesity, dyslipidemia, and increased cardiovascular risk.

Objective: Understanding the effect of visceral adiposity on PCOS is essential for developing targeted therapeutic interventions that address both reproductive and metabolic outcomes.

Conclusion: Recognizing the importance of visceral adiposity in PCOS underscores the need for comprehensive management approaches that extend beyond symptom control to address underlying metabolic derangements. Lifestyle modification, pharmacologic therapy, and novel interventions targeting adipose tissue biology represent key components of an integrated therapeutic strategy.